Home › Research › Topics › amyloid-targeting-therapies
amyloid-targeting-therapies
2 studies tagged amyloid-targeting-therapies, dated 2025-01-01 to 2026-02-28. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
Studies
2 studies carry this tag.
Date range
2025 to 2026
Top journals
- Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 1
- Sage open aging 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Amyloid-targeting therapies represent the first validated disease-modifying strategy for AD but are not definitive solutions.
-
Several approved Alzheimer's disease (AD) treatments help manage its associated cognitive symptoms (e.g., donepezil and memantine) or non-cognitive symptoms.